Your session is about to expire
← Back to Search
3D Reconstruction Planning for Nasal Surgery
Study Summary
This trial is testing a new way to plan surgeries to reconstruct patients' noses, using 3D scanning and printing instead of the standard method.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am between 18 and 100 years old.I am scheduled for nasal reconstruction surgery.
- Group 1: Standard of Care Nasal Reconstruction Planning
- Group 2: 3D Nasal Reconstruction Planning
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being accepted into this clinical investigation?
"Affirmative. Clinicaltrials.gov provides evidence that this trial, which was first posted on April 20th 2022, is actively searching for volunteers. A total of 30 participants need to be sourced from a single location."
Do I fulfill the criteria for participating in this medical trial?
"The requirements to join this medical trial necessitate nasal surgical procedures and a participant's age should be between 18-100 years old. At the moment, approximately 30 people are eligible for enrolment."
Does this medical experiment have an age requirement, and if so, what is the cut-off?
"This medical trial is selecting participants that are 18 years and older, yet not over 100."
Is recruitment for this medical experiment still underway?
"Affirmative. The clinicaltrials.gov database suggests that this medical trial is presently seeking to onboard participants; the study was initially posted on April 20th 2022 and last modified on April 25th 2022, requiring 30 patients from a single site."
Share this study with friends
Copy Link
Messenger